Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications

Cited by (321)

Items 301–321 of 321

  1. Use of Vanoxerine Consta In Cocaine Addiction: A Case Report
    Sümeyye DEMİRBAY, Neslihan Cansel, Hatice Birgül Cumurcu, Zehra Alğan · 2019 · Cyprus Turkish Journal of Psychiatry and Psychology
  2. References
    2009 · Wiley eBooks
  3. References
    2016 · Wiley eBooks
  4. Novel pharmacokinetic model to estimate dopamine dynamics in humans using PET
    Dardo G. Tomasi, Peter Manza, Jean Logan, Ehsan Shokri Kojori, Michele-Vera Yonga, Danielle S. Kroll, Dana Feldman, Katherine L. McPherson, Catherine L. Biesecker, Evan Dennis et al. · 2022 · Research Square
  5. EFEITOS OPOSTOS DA IOIMBINA NO CONDICIONAMENTO DE MEDO AO CONTEXTO EM RATOS CARIOCAS DE ALTO E BAIXO CONGELAMENTO
    VICTOR CONCEICAO ROMANO · 2021
  6. Therapeutic Use of Dopamine Enhancers (Stimulants)
    Alessandro Zuddas, Sara Carucci · 2024 · Springer eBooks
  7. Methylphenidate enhances or impairs the cognitive control of Pavlovian bias depending on working memory capacity
    Dirk E. M. Geurts, Hanneke E.M. den Ouden, Jennifer C. Swart, Monja I. Froböse, Sean James Fallon, Jennifer Louise Cook, Roshan Cools · 2024 · eLife
  8. Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance
    Hans Kirschner, Hanna M. Molla, Matthew R. Nassar, Harriet de Wit, Markus Ullsperger · 2024 · eLife
  9. Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance
    Hans Kirschner, Hanna M. Molla, Matthew R. Nassar, Harriet de Wit, Markus Ullsperger · 2024 · eLife
  10. Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance
    Hans Kirschner, Hanna M. Molla, Matthew R. Nassar, Harriet de Wit, Markus Ullsperger · 2025 · eLife
  11. Evaluating the efficacy of ayurvedic intervention as add on to conventional treatment and explore the interaction of epigenetics, neuro/gut biomarkers and neuroimaging in pediatric ADHD (attention deficit hyperactivity disorder)
    Umesh Chikkanna, John Vijay Sagar Kommu, Venkataram Shivakumar, Bharath Holla, Pallavi Suresh Mundada, Kuppan Gokulakrishnan, Monojith Debnath, Rajendra K.M., BN Roopesh, Srinibash Sahoo et al. · 2025 · Medicine Case Reports and Study Protocols
  12. Experiment 7: Lipase-Catalyzed Esterification Under Aqueous Micellar Conditions
    Bruce H. Lipshutz, Hubert Muchalski · 2025 · Elsevier eBooks
  13. Additional file 3 of Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
    Chang, Jung-Chi, Lin, Hsiang-Yuan, Lv, Junglei, Tseng, Wen-Yih Issac, Gau S · 2021 · Figshare
  14. Methylphenidate enhances or impairs the cognitive control of Pavlovian bias depending on working memory capacity
    Dirk E. M. Geurts, Hanneke E.M. den Ouden, Jennifer C. Swart, Monja I. Froböse, Sean James Fallon, Jennifer Louise Cook, Roshan Cools · 2026 · eLife
  15. Serum Prolactin Levels as an Intraindividual Biomarker for Guiding Osmotic-Release Oral System-Methylphenidate Therapy: Three Case Reports
    Tsukasa Murata, Maiko Nagaoka, Masakatsu Sakamoto, Takahiko Nagamine, Noboru Fujise · 2026 · American Journal of Therapeutics
  16. Le contrôle de l'interférence chez les adolescents avec un trouble de l'attention avec ou sans hyperactivité (TDAH)
    Aurélie Grandjean · 2020 · theses.fr (ABES)
  17. The effects of use of medications on striatal dopamine transporter binding assessed by [123I]I-FP-CIT SPECT in patients with Parkinson’s disease from the PPMI cohort
    Abdallah Nour Ali, Ilham Malik, Jan Booij, Youssef Chahid · 2026 · European Journal of Nuclear Medicine and Molecular Imaging
  18. Pharmacological and non-pharmacological modulation of striatal dopamine release: a meta-analysis of [11C]raclopride PET studies
    Mikael R.E. Eklund, Eman Hassanain, Tero Vahlberg, Juho Joutsa, Valtteri Kaasinen · 2026 · Molecular Psychiatry
  19. Addictive Potential of Methylphenidate: A Systematic Review of Human and Preclinical Behavioral, Clinical and Neurobiological Evidence
    Rafał Bieś, Adam Chabrzyk, Katarzyna Zborowska, Krzysztof Krysta, Marek Krzystanek · 2026 · Pharmaceuticals
  20. Stress-induced dorsal striatal dopamine release is associated with changes in functional connectivity to the prefrontal cortex in nicotine-dependent individuals—a preliminary report
    Siyan Fan, Su Jin Kim, Yasmin Zakiniaeiz, Jocelyn Hoye, Bart de Laat, Alaaddin Ibrahimy, Gelsina Stanley, Chiang-Shan R. Li, Kelly Cosgrove, Michelle Hampson et al. · 2026 · Frontiers in Neuroscience
  21. Development of chromatographic methods and their applications for the analysis of chiral drug metabolism by enzymes altered during pregnancy
    Sara Korner-Wyss · 2015 · Repository for Publications and Research Data (ETH Zurich)